Canprecise AI Information

CanPrecise AI is building the world's first Host-Tumour Integrated Engine, designed to shift the paradigm of cancer care from reactive diagnosis ("What do I have?") to intelligent prediction ("Will this treatment work for me?"). Today, nearly 70% of oncology treatment decisions rely on static data like tumour type and stage, often missing the biological nuance of the individual patient. This "one size fits all" approach leads to avoidable toxicity and significant financial waste. We are solving this by fusing biological (micro-level) and clinical (macro-level) data to model the patient's future. Our AI platform predicts tumour response, selects treatments the patient can physically tolerate ("Treatment Stewardship"), and triggers proactive surveillance to catch relapses early.